Clinical Trial Update: Treating Nonalcoholic Steatohepatitis With Pioglitazone [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated pioglitazone for treating nonalcoholic steatohepatitis (NASH); the study completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2011-04-05